Can Novo Nordisk and Eli Lilly regain their former stock market glory? A lot is riding on next year's pills ...

Serena Williams revealed she has been taking a GLP-1 medication as part of her weight loss journey. In newly published ...

Williams left the world of tennis behind back in 2022, when she played the final match of her career in the US Open, but she ...

Serena Williams has just publicly admitted to using GLP-1 medication for weight loss. The 23-time Grand Slam champion says ...

Serena Williams shocked recently when she posted a picture of herself in the gym looking like a completely different person ...

With 23 Grand Slam singles titles and four Olympic gold medals, Serena Williams is undeniably a superathlete. But the 43-year ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...

Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Serena Williams' weight loss was aided GLP-1 medication for weight loss, losing 31 pounds. The tennis legend speaks on ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...